Skip to Content
 

News: Lung Cancer

New algorithm calculates drug synergy; initial tests involve melanoma, lung cancer

Monday, February 25th, 2019

Drug combinations used for the treatment of non-small-cell lung cancer (NSCLC) and melanoma aren’t as effective as they could be. That could change with a new algorithm developed by a cross-disciplinary Vanderbilt University team for calculating drug synergy.

Spalluto, Lewis to lead VA lung screening initiative

Friday, January 18th, 2019

Lucy Spalluto, MD, and Jennifer Lewis, MD, MS, are co-leading the Veterans Affairs-Partnership to increase Access to Lung Screening (VA-PALS) National Program Evaluation, which aims to implement lung screening programs and improve access to early detection of lung cancer for at-risk veterans.

Lung cancer survival signal

Saturday, December 1st, 2018

A recent study shows that a cell receptor, SSTR2, is a candidate biomarker for poor prognosis and a potential therapeutic target for small cell lung cancer.

Combination therapy improves small-cell lung cancer survival

Friday, October 26th, 2018

Patients who received atezolizumab in addition to standard chemotherapy lived two months longer than those treated with chemotherapy alone, according to a recent study published in the New England Journal of Medicine.

Team’s potential lung cancer therapy lands award from SBIR

Thursday, September 27th, 2018

A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research (SBIR) program.

A new target for lung cancer

Tuesday, August 21st, 2018

A recent study suggests that a transporter protein called xCT may be potential therapeutic target in lung cancer.

Lung cancer patients and advocates visit VUMC research labs

Friday, June 15th, 2018

A group of young lung cancer patients and their family members recently toured research laboratories to learn how investigators are working to find better therapies and possibly a cure for the disease.

$8.1 million grant funds new center to research highly aggressive form of lung cancer

Tuesday, June 12th, 2018

The grant from the National Cancer Institute, establishes a research center for advancing the understanding and treatment of small cell lung cancer. Vito Quaranta, M.D., will direct the new center.

New research finds lung cancer risk drops substantially within five years of quitting smoking

Thursday, May 31st, 2018

The risk of lung cancer drops substantially within five years of quitting, according to a new analysis of the landmark Framingham Heart Study by researchers at Vanderbilt University Medical Center.

New method to thwart false positives in CT-lung cancer screening

Thursday, May 24th, 2018

A new technology may allow doctors to better distinguish benign from malignant lung nodules in CT-based lung cancer screening.

Next Page »